Clin2
NCT06163625Possibly a fitRecruiting

Brain activity and memory in treatment-resistant depression

Major Depressive DisorderTreatment Resistant Depression

Part of Mental health clinical trials.

This study looks at how the brain's frontal lobe (DLPFC) works during memory tasks in people with treatment-resistant depression. It compares brain activity between depressed patients and healthy controls using MRI and possibly a brain stimulation technique (rTMS). It aims to understand why some people don't respond to standard treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a current diagnosis of major depressive disorder that is moderate to severe.
  • You have tried at least two antidepressants for this episode without success (or couldn't tolerate them).
  • You are fluent in English and can give informed consent.
  • You do not have bipolar disorder, psychosis, or a history of seizures or other conditions that would make MRI or rTMS unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05813093Recruiting
Brain stimulation and brain scans for hard-to-treat depression

This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.

Toronto, Ontario
NCT03537794Recruiting
Brain scan study in treatment-resistant depression

This study compares brain synaptic density in people with treatment-resistant depression, people with depression that responds to treatment, and healthy controls. It uses a PET scan to measure synaptic density and aims to understand the biological differences.

Toronto, Ontario
NCT04041479Recruiting· Phase 3
Brain-scan guided rTMS for treatment-resistant depression

This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.

Stanford, California
NCT05139862Not yet recruiting
Predicting treatment response for depression using brain and heart tests

This study is testing whether brain and heart signals can help predict who will respond to rTMS, a non-invasive treatment that uses magnetic pulses to stimulate parts of the brain. You would receive rTMS for depression and undergo MRI scans and heart monitoring to see if certain patterns predict improvement.

Vancouver, British Columbia
NCT05607654Recruiting
Brain stimulation for depression that hasn’t improved with usual treatment

This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.

Hangzhou, Zhejiang
NCT07188753Not yet recruiting
Magnetic brain stimulation for depression with memory problems

This study tests a non-invasive brain stimulation treatment for older adults with depression and some memory or thinking issues. The goal is to see if this magnetic stimulation can safely improve mood, and it is guided by brain imaging.

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.